Stay updated on Inhaled Imatinib for PAH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.

Latest updates to the Inhaled Imatinib for PAH Clinical Trial page
- Check6 days agoChange DetectedThe record presents details of the IMPAHCT study of inhaled imatinib for pulmonary arterial hypertension, including its design, eligibility, locations, and outcomes. It reports that the study was terminated after AV-101 did not demonstrate efficacy at the evaluated doses.SummaryDifference100%

- Check13 days agoChange DetectedThe site's footer revision label changed from v3.7.2 to v3.8.0 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA sitewide NIH notice about terminology changes appears above the page, which continues to show a 403 Forbidden error. The footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedAccess to the study record page is blocked by a 403 Forbidden error, replacing the detailed trial information with an error screen. The page now shows a minimal header and a Home link instead of study details and locations.SummaryDifference17%

- Check62 days agoChange DetectedThe page shows a new Revision: v3.7.0, replacing Revision: v3.6.6, indicating a deployment or update of the page's underlying version.SummaryDifference0.1%

Stay in the know with updates to Inhaled Imatinib for PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.